Blog
/
Policy & Regulation
Policy & Regulation
FDA decisions, coverage rules, and regulatory changes that affect GLP-1 access.
Is Your Compounding Pharmacy Actually at Risk? 503A vs 503B Explained for GLP-1 Patients
The FDA's 503B proposal alarmed GLP-1 patients — but most are through 503A pharmacies, which are a different category entirely. Here's what it actually means.
May 26, 2026 · 5 min read